Disclosures Amid COVID-19: “None of This Has Been Done Before”
Once the dust finally settles from the COVID-19 crisis, the last thing issuers will want is to face an inquiry and possible enforcement action by the SEC.
Disney Earnings Plunge Amid Park Closures
“Disney has gone from being on top of the world a la Lion King, to feeling like Eeyore stuck in the middle of a perfect storm with no end in sight."
COVID-19 Highlights Need to Reset SEC Proposal on MD&A Disclosures
Now is not the time to eliminate important investor information. It is a time to enhance and improve some of the key sections of registrant filings.
SEC Questions COVID Drug Claims of Biotechs
The commission has halted trading in the shares of three companies that have said they are developing a drug candidate for treating COVID-19.
Tyson Foods Shares Dive on 15% Profit Drop
The company expects coronavirus-related disruptions will “increase our operating costs and negatively impact our volumes" for the rest of this year.
Retailers: Your Lenders Are Watching You
The key to survival in a recession is to anticipate a lender’s every move and every question.
Exxon Posts $610M Loss Amid Oil Price Dive
“COVID-19 has significantly impacted near-term demand, resulting in oversupplied markets and unprecedented pressure on commodity prices and margins."
Amazon’s Q1 Profit Dips on COVID Response
The company expects to plow its entire Q2 operating profit back into "getting products to customers and keeping employees safe.”
Fed Expands Main Street Lending Program
The new program widens the pool of applicants and adds loan types.
What COVID-19 Has Revealed About Working Remotely
Use these three insights to improve remote work in the wake of the pandemic.
LabCorp Loses $317M as Test Demand Slumps
“During the first quarter, both diagnostics and drug development began experiencing the impact of the global pandemic," CEO Adam Schecter says.